# EDGAR Filing Document

**Accession Number:** 0001787400
**File Stem:** 0000000000-26-003267
**Filing Date:** 2026-3
**Character Count:** 2141
**Document Hash:** cd1519c11d6ab2f6263da58c55c0f358
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-003267.hdr.sgml**: 20260501

**ACCESSION NUMBER**: 0000000000-26-003267

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260331

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nkarta, Inc.
- **CENTRAL INDEX KEY:** 0001787400
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 474515206
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-294611

**BUSINESS ADDRESS:**
- **STREET 1:** 1150 VETERANS BOULEVARD
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
- **BUSINESS PHONE:** (925) 407-1049

**MAIL ADDRESS:**
- **STREET 1:** 1150 VETERANS BOULEVARD
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001140361-26-011152

## Text-Extract

```

                                                           March 31, 2026

Paul Hasting
Chief Executive Officer
Nkarta, Inc.
1150 Veterans Boulevard
South San Francisco, CA 94080

       Re: Nkarta, Inc.
           Registration Statement on Form S-3
           Filed March 25, 2026
           File No. 333-294611
Dear Paul Hasting:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Doris Stacey Gama at 202-551-3188 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:    Brandon N. Wachs

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._